Laurion Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-68,000
| Closed | -$3.17M | – | 550 |
|
|
2024
Q1 | $3.17M | Buy |
+68,000
| New | +$3.17M | 0.03% | 148 |
|
|
2021
Q3 | – | Sell |
-2,918
| Closed | -$278K | – | 581 |
|
|
2021
Q2 | $278K | Buy |
+2,918
| New | +$278K | ﹤0.01% | 389 |
|
|
2020
Q3 | – | Sell |
-6,848
| Closed | -$536K | – | 839 |
|
|
2020
Q2 | $536K | Buy |
+6,848
| New | +$536K | 0.01% | 392 |
|
|
2020
Q1 | – | Sell |
-17,515
| Closed | -$748K | – | 673 |
|
|
2019
Q4 | $748K | Sell |
17,515
-9,685
| -36% | -$414K | 0.01% | 267 |
|
|
2019
Q3 | $1.16M | Buy |
+27,200
| New | +$1.16M | 0.01% | 253 |
|
|
2019
Q2 | – | Sell |
-19,823
| Closed | -$1.38M | – | 789 |
|
|
2019
Q1 | $1.38M | Buy |
+19,823
| New | +$1.38M | 0.02% | 246 |
|
|
2017
Q1 | – | Sell |
-2,900
| Closed | -$204K | – | 1045 |
|
|
2016
Q4 | $204K | Buy |
+2,900
| New | +$204K | ﹤0.01% | 575 |
|